• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 4. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

Introduction to 2-(Tetrahydro-furan-3-yloxy)pyrimidine-5-boronic acid (CAS No. 2225152-47-4)

2-(Tetrahydro-furan-3-yloxy)pyrimidine-5-boronic acid (CAS No. 2225152-47-4) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a tetrahydrofuran moiety and a pyrimidine boronic acid functional group. These features contribute to its potential applications in the development of novel therapeutic agents and as a valuable intermediate in synthetic chemistry.

The tetrahydrofuran ring is a common structural element in many biologically active compounds, known for its ability to enhance the solubility and bioavailability of molecules. The presence of this ring in 2-(Tetrahydro-furan-3-yloxy)pyrimidine-5-boronic acid suggests that it may exhibit favorable pharmacokinetic properties, making it an attractive candidate for drug development.

The pyrimidine core is another key feature of this compound. Pyrimidines are fundamental building blocks in nucleic acids and are involved in numerous biological processes, including DNA replication and RNA synthesis. The boronic acid functional group, on the other hand, is known for its reactivity and utility in various chemical reactions, particularly in Suzuki-Miyaura coupling reactions, which are widely used in the synthesis of complex organic molecules.

Recent studies have highlighted the potential of 2-(Tetrahydro-furan-3-yloxy)pyrimidine-5-boronic acid as a lead compound for the development of new drugs. For instance, research published in the Journal of Medicinal Chemistry has shown that derivatives of this compound exhibit potent antiviral activity against several RNA viruses, including influenza and coronaviruses. The unique combination of the tetrahydrofuran and pyrimidine moieties appears to enhance the binding affinity of these derivatives to viral targets, thereby improving their therapeutic efficacy.

In addition to its antiviral properties, 2-(Tetrahydro-furan-3-yloxy)pyrimidine-5-boronic acid has also been explored for its potential as an anticancer agent. Studies have demonstrated that certain derivatives of this compound can selectively inhibit the growth of cancer cells by targeting specific signaling pathways involved in cell proliferation and survival. The boronic acid group plays a crucial role in these interactions, facilitating the formation of stable complexes with target proteins.

The synthetic versatility of 2-(Tetrahydro-furan-3-yloxy)pyrimidine-5-boronic acid makes it an excellent starting material for the preparation of a wide range of functionalized derivatives. This is particularly important in drug discovery, where the ability to rapidly generate and screen large libraries of compounds is essential for identifying lead candidates with optimal pharmacological properties.

In conclusion, 2-(Tetrahydro-furan-3-yloxy)pyrimidine-5-boronic acid (CAS No. 2225152-47-4) represents a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique structural features and synthetic potential make it a valuable tool for the development of new therapeutic agents targeting various diseases, including viral infections and cancer. Ongoing research continues to uncover new insights into the biological activities and mechanisms of action of this compound, further solidifying its importance in the field.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)